“ Risperdal is indicated for the short-term symptomatic treatment (up to 6 weeks) of severe persistent aggression in conduct or other disruptive behaviour disorder in children from the age of 5 years and adolescents with subaverage intellectual functioning or mental retardation diagnosed according to DSM-IV criteria, in whom the severity of aggressive or other disruptive behaviours require pharmacologic treatment.